80 FR 44358 - Statement of Organization, Functions and Delegations of Authority

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 80, Issue 143 (July 27, 2015)

Page Range		44358-44359
FR Document		2015-18415

Federal Register, Volume 80 Issue 143 (Monday, July 27, 2015)

[Federal Register Volume 80, Number 143 (Monday, July 27, 2015)]
[Notices]
[Pages 44358-44359]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-18415]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Statement of Organization, Functions and Delegations of Authority

    This notice amends part R of the Statement of Organization, 
Functions and Delegations of Authority of the Department of Health and 
Human Services (HHS), Health Resources and Services Administration 
(HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 80 
FR 37639-37640 dated July 1, 2015).
    This notice reflects organizational changes in the Health Resources 
and Services Administration (HRSA), Maternal and Child Health Bureau 
(RM). Specifically, this notice: (1) Establishes the Office of Policy 
and Planning (RMA); (2) transfers the current Office of Policy 
Coordination (RM10) function to the newly established Office of Policy 
and Planning (RMA); and (3) abolishes the Office of Policy and 
Coordination (RM10).

Chapter RM--Maternal and Child Health Bureau

Section RM--00, Mission

    To provide national leadership, in partnership with key 
stakeholders, to improve the physical and mental health, safety and 
well-being of the maternal and child health (MCH) population which 
includes all of the nation's women, infants, children, adolescents, and 
their families, including fathers and children with special health care 
needs.

Section RM-10, Organization

    Delete the organization for the Maternal and Child Health Bureau 
(RM) in its entirety and replace with the following:
    The Maternal and Child Health Bureau (RM) is headed by the 
Associate Administrator, who reports directly to the Administrator, 
Health Resources and Services Administration. The Maternal and Child 
Health Bureau includes the following components:
    (1) Office of the Associate Administrator (RM);
    (2) Office of Operations and Management (RM1);
    (3) Office of Policy and Planning (RMA);
    (4) Division of Services for Children with Special Health Needs 
(RM2);
    (5) Division of Child, Adolescent and Family Health (RM3);
    (6) Division of MCH Workforce Development (RM4);
    (7) Division of Healthy Start and Perinatal Services (RM5);
    (8) Division of State and Community Health (RM6);
    (9) Division of Home Visiting and Early Childhood Systems (RM8); 
and
    (10) Office of Epidemiology and Research (RM9).

Section RM-20, Functions

    This notice reflects organizational changes in the Health Resources 
and Services Administration (HRSA), Maternal and Child Health Bureau 
(RM). Specifically, this notice: (1) Establishes the Office of Policy 
and Planning (RMA); (2) transfers the Office of Policy Coordination 
(RM10) function to the newly established Office of Policy and Planning 
(RMA); and (3) abolishes the Office of Policy and Coordination (RM10).
    Delete the function for the Office of Policy Coordination (RM10), 
and replace in its entirety.

Office of Policy and Planning (RMA)

    The Office of Policy and Planning (OPP) serves as the Maternal and 
Child Health Bureau (MCHB) focal point for the development of MCHB 
policy and program planning. Specifically, the Office: (1) Supports the 
Office of the Associate Administrator in identifying, planning, and 
implementing policy and program priorities across MCHB; (2) works 
closely with the Office of the Associate Administrator to develop 
strategic plans, facilitate program alignment, and support special 
initiatives; (3) advises and assists in the development, coordination 
and management of program and policy documents, and responses to 
departmental and HRSA initiatives; and (4) coordinates with other 
components within HRSA and HHS, federal agencies, state and local 
governments, and other public and private organizations on issues 
affecting MCHB programs and policies.

[[Page 44359]]

Delegations of Authority

    All delegations of authority and re-delegations of authority made 
to HRSA officials that were in effect immediately prior to this 
reorganization, and that are consistent with this reorganization, shall 
continue in effect pending further re-delegation.
    This reorganization is effective upon date of signature.

    Dated: July 15, 2015.
James Macrae,
Acting Administrator.
[FR Doc. 2015-18415 Filed 7-24-15; 8:45 am]
BILLING CODE 4165-15-P

44358 Federal Register / Vol. 80, No. 143 / Monday, July 27, 2015 / Notices

data to support analytical IV. Electronic Access The Maternal and Child Health
methodologies. The recommendations Bureau (RM) is headed by the Associate
in this guidance apply to new drug Persons with access to the Internet Administrator, who reports directly to
applications, abbreviated new drug may obtain the document at http:// the Administrator, Health Resources
applications, biologics license www.fda.gov/Drugs/ and Services Administration. The
applications, and supplements to these GuidanceCompliance Maternal and Child Health Bureau
applications. The principles in this RegulatoryInformation/Guidances/ includes the following components:
guidance also apply to Type II drug default.htm, http://www.fda.gov/ (1) Office of the Associate
master files. This guidance does not BiologicsBloodVaccines/ Administrator (RM);
address investigational new drug GuidanceCompliance (2) Office of Operations and
application (IND) methods validation RegulatoryInformation/default.htm, or Management (RM1);
specifically, but the principles being http://www.regulations.gov. (3) Office of Policy and Planning
discussed may be helpful to sponsors Dated: July 21, 2015. (RMA);
preparing INDs. Leslie Kux, (4) Division of Services for Children
with Special Health Needs (RM2);
This guidance complements the Associate Commissioner for Policy.
(5) Division of Child, Adolescent and
International Conference on [FR Doc. 2015–18270 Filed 7–24–15; 8:45 am] Family Health (RM3);
Harmonisation guidance ‘‘Q2(R1) BILLING CODE 4164–01–P (6) Division of MCH Workforce
Validation of Analytical Procedures: Development (RM4);
Text and Methodology.’’ (7) Division of Healthy Start and
In the Federal Register of February DEPARTMENT OF HEALTH AND Perinatal Services (RM5);
19, 2014 (79 FR 9467), this guidance HUMAN SERVICES (8) Division of State and Community
was published as a draft guidance. We Health (RM6);
have carefully reviewed and considered Health Resources and Services (9) Division of Home Visiting and
the comments that were received on the Administration Early Childhood Systems (RM8); and
draft guidance and have made changes (10) Office of Epidemiology and
for clarification. Statement of Organization, Functions Research (RM9).
and Delegations of Authority
This guidance is being issued Section RM–20, Functions
consistent with FDA’s good guidance This notice amends part R of the
practices regulation (21 CFR 10.115). This notice reflects organizational
Statement of Organization, Functions changes in the Health Resources and
The guidance represents the current and Delegations of Authority of the
thinking of FDA on analytical Services Administration (HRSA),
Department of Health and Human Maternal and Child Health Bureau (RM).
procedures and methods validation. It Services (HHS), Health Resources and
does not establish any rights for any Specifically, this notice: (1) Establishes
Services Administration (HRSA) (60 FR the Office of Policy and Planning
person and is not binding on FDA or the 56605, as amended November 6, 1995; (RMA); (2) transfers the Office of Policy
public. You can use an alternative as last amended at 80 FR 37639–37640 Coordination (RM10) function to the
approach if it satisfies the requirements dated July 1, 2015). newly established Office of Policy and
of the applicable statutes and This notice reflects organizational Planning (RMA); and (3) abolishes the
regulations. changes in the Health Resources and Office of Policy and Coordination
II. The Paperwork Reduction Act of Services Administration (HRSA), (RM10).
1995 Maternal and Child Health Bureau (RM). Delete the function for the Office of
Specifically, this notice: (1) Establishes Policy Coordination (RM10), and
This guidance refers to previously the Office of Policy and Planning replace in its entirety.
approved collections of information that (RMA); (2) transfers the current Office of
are subject to review by the Office of Office of Policy and Planning (RMA)
Policy Coordination (RM10) function to
Management and Budget (OMB) under the newly established Office of Policy The Office of Policy and Planning
the Paperwork Reduction Act of 1995 and Planning (RMA); and (3) abolishes (OPP) serves as the Maternal and Child
(44 U.S.C. 3501–3520). The collections the Office of Policy and Coordination Health Bureau (MCHB) focal point for
of information in 21 CFR part 211, 21 (RM10). the development of MCHB policy and
CFR part 314, and 21 CFR part 601 have program planning. Specifically, the
been approved under OMB control Chapter RM—Maternal and Child Office: (1) Supports the Office of the
numbers 0910–0139, 0910–0001, and Health Bureau Associate Administrator in identifying,
0910–0338. Section RM—00, Mission planning, and implementing policy and
III. Comments program priorities across MCHB; (2)
To provide national leadership, in works closely with the Office of the
Interested persons may submit either partnership with key stakeholders, to Associate Administrator to develop
electronic comments regarding this improve the physical and mental health, strategic plans, facilitate program
document to http://www.regulations.gov safety and well-being of the maternal alignment, and support special
or written comments to the Division of and child health (MCH) population initiatives; (3) advises and assists in the
Dockets Management (see ADDRESSES). It which includes all of the nation’s development, coordination and
is only necessary to send one set of women, infants, children, adolescents, management of program and policy
comments. Identify comments with the and their families, including fathers and documents, and responses to
tkelley on DSK3SPTVN1PROD with NOTICES

docket number found in brackets in the children with special health care needs. departmental and HRSA initiatives; and
heading of this document. Received Section RM–10, Organization (4) coordinates with other components
comments may be seen in the Division within HRSA and HHS, federal
of Dockets Management between 9 a.m. Delete the organization for the agencies, state and local governments,
and 4 p.m., Monday through Friday, and Maternal and Child Health Bureau (RM) and other public and private
will be posted to the docket at http:// in its entirety and replace with the organizations on issues affecting MCHB
www.regulations.gov. following: programs and policies.

VerDate Sep<11>2014 18:58 Jul 24, 2015 Jkt 235001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1

Federal Register / Vol. 80, No. 143 / Monday, July 27, 2015 / Notices 44359

Delegations of Authority Dated: July 21, 2015. Related to Neurological Disorders; 93.854,
Carolyn Baum, Biological Basis Research in the
All delegations of authority and re- Program Analyst, Office of Federal Advisory Neurosciences, National Institutes of Health,
delegations of authority made to HRSA Committee Policy. HHS)
officials that were in effect immediately [FR Doc. 2015–18244 Filed 7–24–15; 8:45 am] Dated: July 21, 2015.
prior to this reorganization, and that are BILLING CODE 4140–01–P Carolyn Baum,
consistent with this reorganization, Program Analyst, Office of Federal Advisory
shall continue in effect pending further Committee Policy.
re-delegation. DEPARTMENT OF HEALTH AND [FR Doc. 2015–18245 Filed 7–24–15; 8:45 am]
This reorganization is effective upon HUMAN SERVICES BILLING CODE 4140–01–P
date of signature.
National Institutes of Health
Dated: July 15, 2015.
DEPARTMENT OF HEALTH AND
James Macrae, National Institute of Neurological
HUMAN SERVICES
Acting Administrator. Disorders and Stroke; Notice of Closed
[FR Doc. 2015–18415 Filed 7–24–15; 8:45 am]
Meetings National Institutes of Health
BILLING CODE 4165–15–P Pursuant to section 10(d) of the
Federal Advisory Committee Act, as National Institute on Drug Abuse;
amended (5 U.S.C. App.), notice is Notice of Meeting
DEPARTMENT OF HEALTH AND hereby given of the following meetings. Pursuant to section 10(d) of the
HUMAN SERVICES The meetings will be closed to the
Federal Advisory Committee Act, as
public in accordance with the
amended (5 U.S.C. App.), notice is
National Institutes of Health provisions set forth in sections
hereby given of a meeting of the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institute of Arthritis and National Advisory Council on Drug
as amended. The grant applications and
Musculoskeletal and Skin Diseases; Abuse.
the discussions could disclose
Notice of Closed Meeting confidential trade secrets or commercial The meeting will be open to the
property such as patentable material, public as indicated below, with
Pursuant to section 10(d) of the and personal information concerning attendance limited to space available.
Federal Advisory Committee Act, as individuals associated with the grant Individuals who plan to attend and
amended (5 U.S.C. App.), notice is applications, the disclosure of which need special assistance, such as sign
hereby given of the following meeting. would constitute a clearly unwarranted language interpretation or other
invasion of personal privacy. reasonable accommodations, should
The meeting will be closed to the
notify the Contact Person listed below
public in accordance with the Name of Committee: National Institute of in advance of the meeting.
provisions set forth in sections Neurological Disorders and Stroke Special
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Emphasis Panel; E01 Parkinson’s Disease The meeting will be closed to the
as amended. The grant applications and Biomarker Samples. public in accordance with the
the discussions could disclose Date: July 30, 2015. provisions set forth in sections
Time: 1:00 p.m. to 3:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
confidential trade secrets or commercial
Agenda: To review and evaluate grant as amended. The grant applications
property such as patentable material, applications.
and personal information concerning and/or contract proposals and the
Place: National Institutes of Health,
individuals associated with the grant Neuroscience Center, 6001 Executive discussions could disclose confidential
applications, the disclosure of which Boulevard, Rockville, MD 20852, (Telephone trade secrets or commercial property
would constitute a clearly unwarranted Conference Call). such as patentable material, and
invasion of personal privacy. Contact Person: Joel A. Saydoff, Ph.D., personal information concerning
Scientific Review Officer, Scientific Review individuals associated with the grant
Name of Committee: National Institute of Branch, Division of Extramural Research, applications and/or contract proposals,
Arthritis and Musculoskeletal and Skin NINDS/NIH/DHHS/Neuroscience Center, the disclosure of which would
Diseases Special Emphasis Panel Validation 6001 Executive Boulevard, Suite 3205, MSC
9529, Bethesda, MD 20892–9529, 301–435– constitute a clearly unwarranted
of Pediatric Patient Reported Outcomes in
9223, joel.saydoff@nih.gov. invasion of personal privacy.
Chronic Diseases.
Date: August 13–14, 2015 Name of Committee: National Institute of Name of Committee: National Advisory
Time: 8:00 a.m. to 5:00 p.m. Neurological Disorders and Stroke Special Council on Drug Abuse.
Emphasis Panel; K99/R00 Review. Date: September 1–2, 2015.
Agenda: To review and evaluate grant
Date: July 31, 2015. Closed: September 1, 2015, 1:00 p.m. to
applications. Time: 2:00 p.m. to 4:00 p.m. 4:00 p.m.
Place: Embassy Suites at the Chevy Chase Agenda: To review and evaluate grant Agenda: To review and evaluate grant
Pavilion, 4300 Military Road NW., applications. applications and/or proposals.
Washington, DC 20015. Place: National Institutes of Health, Place: National Institutes of Health,
Contact Person: Kan Ma, Ph.D., Scientific Neuroscience Center, 6001 Executive Neuroscience Center, 6001 Executive
Review Officer, Scientific Review Branch, Boulevard, Rockville, MD 20852, (Telephone Boulevard, Rockville, MD 20852.
National Institute of Arthritis, Conference Call). Open: September 2, 2015, 8:00 a.m. to 2:00
Musculoskeletal and Skin Diseases, NIH, Contact Person: Elizabeth A Webber, Ph.D., p.m.
Scientific Review Officer, Scientific Review Agenda: This portion of the meeting will
tkelley on DSK3SPTVN1PROD with NOTICES

6701 Democracy Boulevard, Suite 814,
Branch, Division of Extramural Research, be open to the public for announcements and
Bethesda, MD 20892, 301–451–4838, mak2@
NINDS/NIH/DHHS/Neuroscience Center, reports of administrative, legislative, and
mail.nih.gov. 6001 Executive Boulevard, Suite 3208, MSC program developments in the drug abuse
(Catalogue of Federal Domestic Assistance 9529, Bethesda, MD 20892–9529, 301–496– field.
Program Nos. 93.846, Arthritis, 1917, webbere@mail.nih.gov. Place: National Institutes of Health,
Musculoskeletal and Skin Diseases Research, (Catalogue of Federal Domestic Assistance Neuroscience Center, 6001 Executive
National Institutes of Health, HHS) Program Nos. 93.853, Clinical Research Boulevard, Rockville, MD 20852.

VerDate Sep<11>2014 18:58 Jul 24, 2015 Jkt 235001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1

Document Created: 2018-02-23 09:26:50
Document Modified: 2018-02-23 09:26:50

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		80 FR 44358

80 FR 44358 - Statement of Organization, Functions and Delegations of Authority

DEPARTMENT OF HEALTH AND HUMAN SERVICESHealth Resources and Services Administration

Federal Register Volume 80, Issue 143 (July 27, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration